Cargando…
Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model
Atherosclerosis may lead to cardiovascular diseases (CVD), which are the primary cause of death globally. In addition to conventional therapeutics for CVD, use of nutraceuticals that prevents cholesterol deposition, reduce existing plaques and hence anti-atherosclerotic effects of nutraceuticals app...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695206/ https://www.ncbi.nlm.nih.gov/pubmed/33171640 http://dx.doi.org/10.3390/ph13110372 |
_version_ | 1783615137372962816 |
---|---|
author | Almowallad, Sanaa Huwait, Etimad Al-Massabi, Rehab Saddeek, Salma Gauthaman, Kalamegam Prola, Alexandre |
author_facet | Almowallad, Sanaa Huwait, Etimad Al-Massabi, Rehab Saddeek, Salma Gauthaman, Kalamegam Prola, Alexandre |
author_sort | Almowallad, Sanaa |
collection | PubMed |
description | Atherosclerosis may lead to cardiovascular diseases (CVD), which are the primary cause of death globally. In addition to conventional therapeutics for CVD, use of nutraceuticals that prevents cholesterol deposition, reduce existing plaques and hence anti-atherosclerotic effects of nutraceuticals appeared to be promising. As such, in the present study we evaluated the beneficial effects of punicalagin, a phytochemical against an atherosclerotic cell model in vitro. Cytotoxicity assays were examined for 10 µM concentration of punicalagin on THP-1 macrophages. Real-time-polymerase chain reaction (RT-PCR) was used to analyze monocyte chemoattractant protein-1 (MCP-1) and Intercellular adhesion molecule (ICAM-1) expressions. Monocyte migration and cholesterol efflux assays were performed to investigate punicalagin’s further impact on the key steps of atherosclerosis. Cytotoxicity assays demonstrated no significant toxicity for punicalagin (10 µM) on THP-1 macrophages. Punicalagin inhibited the IFN-γ-induced overexpression of MCP-1 and ICAM-1 in macrophages by 10 fold and 3.49 fold, respectively, compared to the control. Punicalagin also reduced the MCP-1- mediated migration of monocytes by 28% compared to the control. Percentages of cellular cholesterol efflux were enhanced in presence or absence of IFN-γ by 88% and 84% compared to control with 58% and 62%, respectively. Punicalagin possesses anti-inflammatory and anti-atherosclerotic effects. Punicalagin also did not exhibit any cytotoxicity and therefore can be considered a safe and potential candidate for the treatment and prevention of atherosclerosis. |
format | Online Article Text |
id | pubmed-7695206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76952062020-11-28 Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model Almowallad, Sanaa Huwait, Etimad Al-Massabi, Rehab Saddeek, Salma Gauthaman, Kalamegam Prola, Alexandre Pharmaceuticals (Basel) Article Atherosclerosis may lead to cardiovascular diseases (CVD), which are the primary cause of death globally. In addition to conventional therapeutics for CVD, use of nutraceuticals that prevents cholesterol deposition, reduce existing plaques and hence anti-atherosclerotic effects of nutraceuticals appeared to be promising. As such, in the present study we evaluated the beneficial effects of punicalagin, a phytochemical against an atherosclerotic cell model in vitro. Cytotoxicity assays were examined for 10 µM concentration of punicalagin on THP-1 macrophages. Real-time-polymerase chain reaction (RT-PCR) was used to analyze monocyte chemoattractant protein-1 (MCP-1) and Intercellular adhesion molecule (ICAM-1) expressions. Monocyte migration and cholesterol efflux assays were performed to investigate punicalagin’s further impact on the key steps of atherosclerosis. Cytotoxicity assays demonstrated no significant toxicity for punicalagin (10 µM) on THP-1 macrophages. Punicalagin inhibited the IFN-γ-induced overexpression of MCP-1 and ICAM-1 in macrophages by 10 fold and 3.49 fold, respectively, compared to the control. Punicalagin also reduced the MCP-1- mediated migration of monocytes by 28% compared to the control. Percentages of cellular cholesterol efflux were enhanced in presence or absence of IFN-γ by 88% and 84% compared to control with 58% and 62%, respectively. Punicalagin possesses anti-inflammatory and anti-atherosclerotic effects. Punicalagin also did not exhibit any cytotoxicity and therefore can be considered a safe and potential candidate for the treatment and prevention of atherosclerosis. MDPI 2020-11-08 /pmc/articles/PMC7695206/ /pubmed/33171640 http://dx.doi.org/10.3390/ph13110372 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Almowallad, Sanaa Huwait, Etimad Al-Massabi, Rehab Saddeek, Salma Gauthaman, Kalamegam Prola, Alexandre Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model |
title | Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model |
title_full | Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model |
title_fullStr | Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model |
title_full_unstemmed | Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model |
title_short | Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model |
title_sort | punicalagin regulates key processes associated with atherosclerosis in thp-1 cellular model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695206/ https://www.ncbi.nlm.nih.gov/pubmed/33171640 http://dx.doi.org/10.3390/ph13110372 |
work_keys_str_mv | AT almowalladsanaa punicalaginregulateskeyprocessesassociatedwithatherosclerosisinthp1cellularmodel AT huwaitetimad punicalaginregulateskeyprocessesassociatedwithatherosclerosisinthp1cellularmodel AT almassabirehab punicalaginregulateskeyprocessesassociatedwithatherosclerosisinthp1cellularmodel AT saddeeksalma punicalaginregulateskeyprocessesassociatedwithatherosclerosisinthp1cellularmodel AT gauthamankalamegam punicalaginregulateskeyprocessesassociatedwithatherosclerosisinthp1cellularmodel AT prolaalexandre punicalaginregulateskeyprocessesassociatedwithatherosclerosisinthp1cellularmodel |